한국 비만성인의 대사증후군 유병에 따른 내장지방지수와 인슐린저항성, 췌장 베타세포기능과의 관련성

키워드

참고문헌 (36)

1. Steven E. Kahn, "Mechanisms linking obesity to insulin resistance and type 2 diabetes", Nature, 444(7121), pp.840~846 (2006), Springer Science and Business Media LLC[DOI]
2. Dexter Canoy, "Body Fat Distribution and Risk of Coronary Heart Disease in Men and Women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort", Circulation, 116(25), pp.2933~2943 (2007), Ovid Technologies (Wolters Kluwer Health)[DOI]
3. Michelle Lee, "Weight Management for Type 2 Diabetes Mellitus: Global Cardiovascular Risk Reduction", The American Journal of Cardiology, 99(4), pp.68~79 (2007), Elsevier BV[DOI]
4. A. Shuster, "The clinical importance of visceral adiposity : a critical review of methods for visceral adipose tissue analysis", The British Journal of Radiology, 85(1009), pp.1~10 (2012)[DOI]
5. K. M. Knowles, "Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults", International Journal of Hypertension, 24, pp.931402~ (2011)[DOI]
6. Marie-Christine Pouliot, "Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women", The American Journal of Cardiology, 73(7), pp.460~468 (1994), Elsevier BV[DOI]
7. M. C. Amato, "Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk", Diabetes Care, 33(4), pp.920~922 (2010), American Diabetes Association[DOI]
8. T Du, "Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009", International Journal of Obesity, 38(6), pp.840~847 (2014), Springer Science and Business Media LLC[DOI]
9. Jee-Young Oh, "The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome", Obesity, 21(8), pp.1690~1694 (2013), Wiley[DOI]
10. Guilherme Ardenghi Balsan, "Relationship between adiponectin, obesity and insulin resistance", Revista da Associação Médica Brasileira, 61(1), pp.72~80 (2015), FapUNIFESP (SciELO)[DOI]
11. S. E. Kahn, "The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes", Diabetologia, 46(1), pp.3~19 (2003), Springer Science and Business Media LLC[DOI]
12. Günter Klöppel, "Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus Revisited", Pathology and Immunopathology Research, 4(2), pp.110~125 (1985), S. Karger AG[DOI]
13. B. L. Wajchenberg., "Beta-cell failure in diabetes and preservation by clinical treatment", Endocrine Reviews, 28(2), pp.187~218 (2007)[DOI]
14. D. R. Matthews, "Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28(7), pp.412~419 (1985), Springer Science and Business Media LLC[DOI]
15. Simona Cernea, "Diabetes and beta cell function: from mechanisms to evaluation and clinical implications", Biochemia Medica, pp.266~280 (2013), Croatian Society for Medical Biochemistry and Laboratory Medicine[DOI]
16. Mohammadreza Bozorgmanesh, "Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study", Lipids in Health and Disease, 9(1), pp.100~ (2010), Springer Science and Business Media LLC[DOI]
17. Nasser M. Al-Daghri, "Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances", European Journal of Clinical Investigation, 43(2), pp.183~189 (2013), Wiley[DOI]
18. Mariusz Stępień, "New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension", Angiology, 65(4), pp.333~342 (2013), SAGE Publications[DOI]
19. Kyung-A Shin, "Usefulness Of Surrogate Markers Of Body Fat Distribution For Predicting Metabolic Syndrome In Middle-Aged And Older Korean Populations", Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 12, pp.2251~2259 (2019), Informa UK Limited[DOI]
20. Sang Woo Oh, "Cut-off Point of BMI and Obesity-Related Comorbidities and Mortality in Middle-Aged Koreans", Obesity Research, 12(12), pp.2031~2040 (2004), Wiley[DOI]
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA: The Journal of the American Medical Association, 285(19), pp.2486~2497 (2001), American Medical Association (AMA)[DOI]
22. The Asia-Pacific perspective : redefining obesity and its treatment, "World Health Organization", Health Communications Australia, ~ (2000)
23. 이시훈, "Cutoff Values of Surrogate Measures of Insulin Resistance for Metabolic Syndrome in Korean Non-diabetic Adults", Journal of Korean Medical Science, 21(4), pp.695~700 (2006), 대한의학회
24. Y. Song, "Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women: The Women's Health Initiative Observational Study", Diabetes Care, 30(7), pp.1747~1752 (2007), American Diabetes Association[DOI]
25. Eugenia E. Calle, "Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms", Nature Reviews Cancer, 4(8), pp.579~591 (2004), Springer Science and Business Media LLC[DOI]
26. Barry M Popkin, "Global nutrition transition and the pandemic of obesity in developing countries", Nutrition Reviews, 70(1), pp.3~21 (2012), Oxford University Press (OUP)[DOI]
27. Jean-Pierre Després, "Abdominal obesity and metabolic syndrome", Nature, 444(7121), pp.881~887 (2006), Springer Science and Business Media LLC[DOI]
28. Emilia Mazzuca, "Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea", Journal of Sleep Research, 23(1), pp.13~21 (2014), Wiley[DOI]
29. Belinda Elisha, "The Visceral Adiposity Index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women – A MONET group study", Applied Physiology, Nutrition, and Metabolism, 38(8), pp.892~899 (2013), Canadian Science Publishing[DOI]
30. Latha Ramalingam, "The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863(5), pp.1106~1114 (2017), Elsevier BV[DOI]
31. N. S. Kalupahana, "The renin-angiotensin system: a link between obesity, inflammation and insulin resistance", Obesity Reviews, 13(2), pp.136~149 (2012), Wiley[DOI]
32. MK Garg, "Study of beta-cell function (by HOMA model) in metabolic syndrome", Indian Journal of Endocrinology and Metabolism, 15(5), pp.44~ (2011), Medknow[DOI]
33. J. B. Dixon, "Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese", Diabetic Medicine, 20(2), pp.127~134 (2003), Wiley[DOI]
34. Hyun Ho Sung, "The association of the visceral adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus", Endocrine Journal, 67(6), pp.613~621 (2020), Japan Endocrine Society[DOI]
35. Ele Ferrannini, "Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects", Endocrine Reviews, 19(4), pp.477~490 (1998), The Endocrine Society[DOI]
36. M. Kasuga, "Insulin resistance and pancreatic   cell failure", Journal of Clinical Investigation, 116(7), pp.1756~1760 (2006), American Society for Clinical Investigation[DOI]

관련 논문AI추천